Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

dry eye

8,714 views

Published on

Published in: Health & Medicine
  • Be the first to comment

dry eye

  1. 1. DONE BYMANOJ.A
  2. 2. What is Dry Eye Disease?Disease of ocular surface caused bydisturbances of natural function andprotection of external eye leading to anunstable tear film when eye is open
  3. 3. Prevalence of Dry Eye DiseaseAverage age of a dry eye patient is 54; most are women.Dry Eye Syndrome affects 75% of people over age 65.Common reason for ophthalmologist visits.
  4. 4. Normal tearing depends on a neuronal feedback loop Secretomotor Nerve ImpulsesLacrimal Glands Tears Support and Maintain Ocular Surface Ocular Surface Neural Stimulation
  5. 5. Inflammation disrupt normal neuronalLacrimal Glands: control of tearing.• Neurogenic Interrupted Secretomotor Inflammation Nerve Impulses• T-cell Activation• Cytokine Secretion into Tears Tears Inflame Ocular Surface Cytokines Disrupt Neural Arc
  6. 6.  A complex mixture of proteins, mucin, and electrolytes  Antimicrobial proteins: Lysozyme, lactofer rin  Growth factors & suppressor s of inflammation: EGF, IL-1RA  Soluble mucin 5AC secreted by goblet cells for viscosity  Electrolytes for proper osmolarity
  7. 7.  Decrease in many proteins Decreased growth factor concentrations Altered cytokine balance promotes inflammation Soluble mucin -5AC g reatly decreased  Due to goblet cell loss  Impacts viscosity of tear film Pr oteases activated Increased electrolytes
  8. 8. ETIOLOGY
  9. 9. AQUEOUS TEAR DEFICIENCY: also known as KCS seen in 1.congenital alacramia 2.paralytic hyposecretion 3.1˚& 2˚ sjogrens disease 4.Riley day syndrome 5.Idiopathic• MUCIN DEFICIENCY: occurs when goblet cells damaged 1.hypovitaminosis A 2.trachoma 3.chemical burns & radiations 4.ocular pemphigoid, SJS
  10. 10. LIPID DEFICIENCY:Rare phenomenaCongenital anhydrotic ectodermal dysplasia with absence of meibomian glandsChronic blepharitis and chronic meibomitisIMPAIRED EYELID FUNCTION:.Bells palsy .Lagophthalmus.Exposure keratitis .ectropion.Dellen.Sympblepheron
  11. 11. EPITHELIOPATHIES:Alteration in cor neal epithelium
  12. 12. Medications T hat MayContributeto Dr y Eye DiseaseSystemic Antihyper tensives • Topical Antiandr ogens – Preservatives in Anticholiner gics Tears Antidepr essants  Antiar rhythmic Dr ugs Par kinson’s Disease Agents Antihistamines
  13. 13. SYMPTOMSIr ritationFor eign body sensationItchingNon specific ocular discomfor tChr onicall y sor e eyes not responding to variety of dr ops instilled
  14. 14. SIGNSString y mucus and par ticulate matter in tear filmLustureless ocular surfaceConjunctival xer osisCor neal changes - punctate epithelial er osions and filaments
  15. 15. Patient Types with HighIncidence of Dr y EyeDisease Women aged 50 or older Women using postmenopausal hor mone replacement therapy T hose with ocular comorbidities Contact lens wearer s Smoker s 1 Schaumberg et al. Am J Ophthalmol. 2003; 2 Schaumberg et al. JAMA. 2001; 3 Lemp. CLAO J. 1995; 4 Multi-Sponsor Surveys, Inc. The 2005 Gallup Study of Dry Eye Sufferers. 2005.
  16. 16. DRY EYESYNDROMES XEROSIS(XEROPHTHALMIA) Dry lustureless condition of conjunctiva due to deficiency of mucin LOCAL OCULAR GENERAL DISEASE AFFECTIONa) Trachoma , burns, Deficiency of vitamin A pemphigoid, diphtheriaCicatricial degeneration Occurrence of bitots of conjunctival spots epitheliumb) Ectropion or proptosis
  17. 17. KERATOCONJUNCTIVITIS SICCA: deficiency of aqueous component of tear s i.e lacrimal tear s primar y secondar ykcs & xer ostomia kcs & rheumatoid ar thritis Pathologically focal accumulation & infiltr ation with l ymphocytes & plasma cells Tear lysozyme r atio of 0.1 -> KCS
  18. 18. DIAGNOSIS1.TEAR FILM BREAK UP TIME(BUT): interval between complete blink & appearance of first randomly distributed dry spot on corneaAfter instilling drops of fluorescein dye, examintion under SLE is carried out with cobalt blue light NORMAL – 15 -35 SECONDS <10 SECS- UNSTABLE TEAR FILMBUT- an indicator of adequacy of mucin component
  19. 19. Schirmer Test: 5 * 35 mm strip of w hatman 41 filter paper folded 5mm fr m one end kept in lower for nix at jn of lateral 1/3 rd & medial 2/3 rd NORMAL >15mm MILD TO MODERATE KCS 5-10 mm
  20. 20. ROSE BENGALSTAININGUseful for detecting even mild cases
  21. 21. TREATMENT1.ARTIFICIAL TEAR DROPS: 0.25 -0.7% methyl cellulose 0.3% hypromellose pol yvinyl alcohol2.MUCOLYTICS: 5% acetylcystine 4times/ day3.TOPICAL RETINOIDS
  22. 22. 4. Restasis ™ Ophthalmic emulsion of cyclosporine 0.05%. Prescription therapy for dry eye disease. Restasis™ is FDA approved to increase tear production in patients whose tear production may be reduced by inflammation of the eye associated with keratoconjunctivitis sicca.
  23. 23. 5.PRESERVATION OF EXISTING TEARS BY REDUCING DECREASING EVAPORATION DRAINAGE: 1. Room temperature 1.Collagen implants 2. Moist chambers 2.Electrocauterisation 3. Protective glasses 3.Cyanoacrylate tissue adhesives 4.Argon laser & surgical occlusions.

×